31 studies found for:    " December 04, 2013":" January 03, 2014"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Rank Status Study
21 Completed A Phase 1, Open Label, Dose-escalation Study of the Safety, Pharmacokinetics and Antiretroviral Activity of 3BNC117
Conditions: Healthy;   HIV
Interventions: Biological: 1 mg/kg, single dose IV administration of 3BNC117;   Biological: 3 mg/kg, single dose IV administration of 3BNC117;   Biological: 10 mg/kg, single dose IV administration of 3BNC117;   Biological: 30 mg/kg, single dose IV administration of 3BNC117;   Biological: 10 mg/kg, two doses IV of 3BNC117;   Biological: 30 mg/kg, two doses IV of 3BNC117
22 Recruiting Mechanisms of Impaired HIV-associated B Cell and Pneumococcal Vaccine Responses
Conditions: HIV;   Pneumococcal Infections;   Pneumococcal Vaccines
Interventions: Biological: PCV-13;   Biological: PPSV-23
23 Recruiting Promoting Uptake and Retention of Option B+ in Malawi
Condition: HIV
Interventions: Other: Community based peer support;   Other: Facility-based Peer Support
24 Unknown  Comprehensive Triaged HIV Prevention in Tanzania
Condition: HIV
Intervention: Behavioral: Comprehensive Triaged HIV Prevention (CTHP)
25 Recruiting Quantifying Drug Adherence and Drug Exposure to Antiretroviral Therapy
Condition: HIV/AIDS
Intervention:
26 Completed Targeted Nurse-driven HIV Screening in Emergency Departments
Condition: Targeted HIV Screening, Emergency Departments
Interventions: Procedure: Nurse-driven HIV targeted screening;   Procedure: Current practice
27 Enrolling by invitation Artefill for the Treatment of HIV-associated Facial Lipoatrophy
Condition: HIV-facial Lipoatrophy
Intervention: Drug: Artefill dermal filler
28 Unknown  Scale-up of an Internet-Delivered Study for HIV+ Men
Condition: HIV
Intervention: Behavioral: Video treatments
29 Completed An Open Label Trial of Pegylated Interferon, Ribavirin and Telaprevir Versus Pegylated Interferon and Ribavirin Alone in the Treatment of Hepatitis C Genotype 1 Virus Infection in Patients With HIV-1 Co-infection
Condition: HIV
Interventions: Drug: Ribavirin;   Drug: Telaprevir
30 Enrolling by invitation Phase 2a Study of Dapivirine Ring in Adolescent Females
Condition: HIV Prevention
Interventions: Device: placebo ring;   Drug: dapivirine ring
31 Active, not recruiting Non‐Communicable Diseases and Antiretroviral Therapy Outcomes in the RapIT Study Population
Conditions: Antiretroviral Therapy, Highly Active;   Diabetes Mellitus, Type 2;   Cardiovascular Diseases
Intervention: Behavioral: Referral for NCD care

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-31) Next Page   
Indicates status has not been verified in more than two years